keynote-a18: pembrolizumab with chemoradiotherapy for advanced cervical cancer
Published 8 months ago • 348 plays • Length 1:14Download video MP4
Download video MP3
Similar videos
-
0:56
keynote-a18: pembro or placebo with chemoradiotherapy in newly diagnosed high-risk cervical cancer
-
3:15
highlights on pembro crt in high-risk locally advanced cervical cancer: the keynote-a18 study
-
2:26
keynote-826: pembrolizumab plus chemotherapy for patients with metastatic cervical cancer
-
1:16
keynote 826: pembrolizumab chemo in patients with advanced cervical cancer
-
2:30
advancements in parp inhibitors for cervical cancer
-
1:37
updates in icis and adcs in cervical cancer
-
6:38
pembrolizumab with chemotherapy as first line for metastatic cervical cancer
-
2:38
pembrolizumab plus chemoradiotherapy shows clinically meaningful improvement in pfs for locally ...
-
6:40
keynote-100 update: pembrolizumab in patients with advanced recurrent ovarian cancer
-
7:03
pembrolizumab for frontline head and neck cancer: keynote-048 results
-
3:23
#esmo23 - prof. sven mahner: keynote a18 studie: pembrolizumab plus chemotherapie beim lokal for...
-
3:07
the keynote-001 trial: a breakthrough for pembrolizumab
-
4:03
keynote-040: groundbreaking results for pembrolizumab in head and neck cancer
-
2:21
final analysis of keynote-585: pembrolizumab and chemotherapy in g/gej cancer
-
3:39
keynote-966: pembrolizumab, gemcitabine and cisplatin for cca
-
1:19
novel immunotherapy-based combination approaches in cervical cancer
-
1:39
pembrolizumab and epacadostat for nsclc: echo-306/keynote-715
-
2:44
pembrolizumab and chemotherapy in advanced nsclc
-
8:45
keynote-590: pembrolizumab plus chemotherapy for advanced oesophageal cancer